RELX PLC: Stock Analysis and Future Predictions

Aug.26.2022
RELX PLC: Stock Analysis and Future Predictions
RELX stock falls slightly to $28.04, with average trading volume of 891,300 shares. Analysts rate it a "buy".

RELX PLC, trading on the New York Stock Exchange as RELX, closed at $28.04 on Wednesday with no change from the previous day's closing price. The average trading volume over the past five days was 891,300 shares. The stock price decreased by $0.82 in the past week, although it has reached a 17-fold high in the last 12 months. The average trading volume over the past 20 days was 660,680 shares, while the 50-day average trading volume was 1,016,512 shares.

 

Last month, shares of RELX fell by 0.85%. The company's stock reached its lowest point of $27.84 per share on August 23, 22. After rebounding to a 52-week high of $32.71 on January 3, the stock hit a low of $24.81 within the 52-week period. So far this year, the stock has reached a new high but has since dropped by 14.01% or $4.57. Despite this, the price is still down 14.28% from its 52-week high.

 

Valuation Metrics

 

The trailing P/E ratio for RELX PLC (RELX) is 29.06. Its beta is 0.74. Other valuation ratios to consider include a P/S ratio of 5.84, a PB ratio of 12.41, and a price-to-cash-flow ratio of 42.80.

 

The company's payout ratio stands at 52.60%. The latest quarterly dividend paid by the company was $0.4443 per share, which reflects a decline of 7.82% compared to the previous year's $0.4820 per share. The most recent dividend decrease of $0.0377 per share was announced on Friday, July 29, 2022.

 

Financial Health

 

Recently, the quick ratio of RELX PLC for the quarter was 0.50 and the current ratio is also 0.50, indicating that the company may not be able to fulfill its debts. Additionally, the company's long-term debt to equity ratio for the recent quarter was 1.63, and the total debt to equity ratio was 1.89. RELX PLC's EBITDA profit margin was 35.31%, while the operating profit margin for the same period was 27.10%. It has been reported that the company's total profit is $6.44 billion and its revenue is $9.96 billion.

 

Profit Surprises

 

The company had a net income of 1.47 billion USD for this quarter, with a revenue growth of 16.79%.

 

From a technical analysis perspective, let's take a brief look at the price trends of RELX PLC (RELX). As of the close on August 24th, the 9-day RSI was 31.06%, indicating the stock is neutral, and the historical volatility during this timeframe was 10.78%.

 

As of today, the price of RELX is $28.49, a decrease of 2.84% compared to its five-day moving average of $0.82. RELX's current trading price is 2.37% lower than its 20-day simple moving average and 9.84% lower than its 100-day SMA. However, its current price is higher than its 50-day SMA by 7.72% but lower than its 200-day SMA by 11.60%.

 

The random values for K and D are 8.36% and 10.25% respectively, with an average true range (ATR) of 0.36. Over a 14-day period, the random value is 11.30% with an average true range of 0.38, while the RSI (14) is 41.09%. The stock's 9-day MACD oscillator has reached -0.46, while the reading for 14 days is -0.59.

 

Analyst rating.

 

Kepler has upgraded RELX PLC (NYSE code: RELX) to a buy rating in its latest analyst report. Previously, the stock was rated as hold. The consensus rating for RELX PLC (RELX) among analysts is overweight. According to current broker recommendations, zero brokerage firms suggest selling RELX while two suggest holding. There are no analysts who rate the stock as underweight. The stock is rated as overweight by zero analysts while one other analyst rates it as a buy.

 

What is RELX's price target for the next 12 months?

 

Analysts predict a target price range of $32.80 to $32.80, with a median target of $32.80 for RELX PLC (RELX) stock. Based on these predictions, the average target price given by analysts is $32.80.

 

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Rotterdam-Area Warehouse Raid Finds 277,000 Illegal Vapes and Nearly 150,000 Nicotine Pouch Boxes
Rotterdam-Area Warehouse Raid Finds 277,000 Illegal Vapes and Nearly 150,000 Nicotine Pouch Boxes
The Dutch Food and Consumer Product Safety Authority, known as the NVWA, seized more than 277,000 illegal vapes near Rotterdam and nearly 150,000 boxes of nicotine pouches in Utrecht and Rotterdam, calling them the largest batches of such products it has found to date. Video footage released by the NVWA shows some cartons in the warehouse bearing the “AL FAKHER / الفاخر” name, though the agency did not identify brands.
Jul.10
Product | ZYN Adds Tropical Flavor and Expands 1.5mg Nicotine Options in the Philippines
Product | ZYN Adds Tropical Flavor and Expands 1.5mg Nicotine Options in the Philippines
ZYN has expanded its nicotine pouch portfolio in the Philippines with the addition of Cool Breeze 1.5mg and Tropical in 3mg and 6mg strengths. Public information shows that 1.5mg is among the lower nicotine strengths offered by ZYN in the Philippine market and is positioned for adult nicotine consumers who are new to nicotine pouches.
PMI
Jun.08
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
New Canadian research shows that 34.8% of people aged 17 to 27 have tried nicotine pouches, up more than fourfold from 7.6% in 2022. The findings come as Conservative politicians, Alberta’s government and the tobacco industry push Ottawa to relax current restrictions on pouch sales.
Jun.12
Nearly Half of Seoul Vape Vending Machines Bypassed by Fake IDs, Raising Youth Access Concerns
Nearly Half of Seoul Vape Vending Machines Bypassed by Fake IDs, Raising Youth Access Concerns
Seoul city authorities inspected 339 tobacco vending machines at e-cigarette retailers and found that 168, or 49.5%, allowed purchases using fake IDs, showing that unmanned retail terminals and adult-verification systems remain a major enforcement gap after e-cigarettes were brought under tobacco regulation.
Market
Jul.03 by 2Firsts Perspectives
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12